These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 3437301

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Gamma-vinyl-GABA treatment of tardive dyskinesia and other movement disorders.
    Stahl SM, Thornton JE, Simpson ML, Berger PA, Napoliello MJ.
    Biol Psychiatry; 1985 Aug; 20(8):888-93. PubMed ID: 3861199
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cerebrospinal fluid GABA and seizure control with vigabatrin.
    Riekkinen PJ, Ylinen A, Halonen T, Sivenius J, Pitkanen A.
    Br J Clin Pharmacol; 1989 Aug; 27 Suppl 1(Suppl 1):87S-94S. PubMed ID: 2757914
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Increased gamma-aminobutyric acid (GABA), homocarnosine and beta-alanine in cerebrospinal fluid of patients treated with gamma-vinyl GABA (4-amino-hex-5-enoic acid).
    Grove J, Schechter PJ, Tell G, Koch-Weser J, Sjoerdsma A, Warter JM, Marescaux C, Rumbach L.
    Life Sci; 1981 May 21; 28(21):2431-9. PubMed ID: 6789022
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gamma-vinyl GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children.
    Arteaga R, Herranz JL, Valdizán EM, Armijo JA.
    Epilepsia; 1992 May 21; 33(5):923-31. PubMed ID: 1396437
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Specificity of vigabatrin for the GABAergic system in human epilepsy.
    Riekkinen PJ, Pitkanen A, Ylinen A, Sivenius J, Halonen T.
    Epilepsia; 1989 May 21; 30 Suppl 3():S18-22. PubMed ID: 2767015
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibitory and excitatory amino acids in CSF of patients suffering from complex partial seizures during chronic treatment with gamma-vinyl GABA (vigabatrin).
    Halonen T, Lehtinen M, Pitkänen A, Ylinen A, Riekkinen PJ.
    Epilepsy Res; 1988 May 21; 2(4):246-52. PubMed ID: 3143562
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients.
    Ben-Menachem E, Persson LI, Schechter PJ, Haegele KD, Huebert N, Hardenberg J, Dahlgren L, Mumford JP.
    Br J Clin Pharmacol; 1989 May 21; 27 Suppl 1(Suppl 1):79S-85S. PubMed ID: 2474312
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.